These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16540733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p16 expression in sentinel nodes with metastatic breast carcinoma: evaluation of its role in developing triaging strategies for axillary node dissection and a marker of poor prognosis.
    Singh M, Parnes MB, Spoelstra N, Bleile MJ, Robinson WA.
    Hum Pathol; 2004 Dec; 35(12):1524-30. PubMed ID: 15619212
    [Abstract] [Full Text] [Related]

  • 3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF.
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [Abstract] [Full Text] [Related]

  • 6. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M.
    Cancer; 2000 Mar 01; 88(5):1099-107. PubMed ID: 10699901
    [Abstract] [Full Text] [Related]

  • 7. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM, Hop WC, Tervoort MA, de Graaf PW.
    Ned Tijdschr Geneeskd; 2004 May 08; 148(19):938-43. PubMed ID: 15160561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Can we define a role for perisentinel lymph-nodes on breast cancer disease?
    Sianesi M, Del Rio P, Martella E, De Notarpietro F, De Simone B, Ghirarduzzi A, Sianesi N, Arcuri MF.
    Ann Ital Chir; 2011 May 08; 82(3):173-7. PubMed ID: 21780557
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E, Auger M.
    Cancer; 2008 Apr 25; 114(2):89-93. PubMed ID: 18286535
    [Abstract] [Full Text] [Related]

  • 11. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB.
    Br J Surg; 2003 Nov 25; 90(11):1354-60. PubMed ID: 14598414
    [Abstract] [Full Text] [Related]

  • 12. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW, Rombouts MC, Ruers TJ, Klinkenbijl JH, Wobbes T.
    Eur J Surg Oncol; 2001 Dec 25; 27(8):719-22. PubMed ID: 11735167
    [Abstract] [Full Text] [Related]

  • 13. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM, Kroon BB, Antonini N, Valdés Olmos RA, Rutgers EJ, Nieweg OE.
    Ann Surg Oncol; 2008 Apr 25; 15(4):1025-31. PubMed ID: 18219534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.
    J Exp Clin Cancer Res; 2000 Jun 25; 19(2):141-4. PubMed ID: 10965808
    [Abstract] [Full Text] [Related]

  • 16. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N.
    Int J Surg Pathol; 2010 Feb 25; 18(1):36-41. PubMed ID: 19448065
    [Abstract] [Full Text] [Related]

  • 17. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, In R, Matsuda N, Nakamura S.
    Clin Breast Cancer; 2013 Dec 25; 13(6):471-7. PubMed ID: 24267732
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC, Fey JV, Borgen PI, Cody HS.
    J Am Coll Surg; 2005 Jan 25; 200(1):10-4. PubMed ID: 15631914
    [Abstract] [Full Text] [Related]

  • 20. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D, Pecha V, Skovajsova M, Zahumensky J, Trnkova M, Petruzelka L, Halaska M, Sottner O, Otcenasek M, Kolarova H.
    Neoplasma; 2013 Jan 25; 60(3):334-42. PubMed ID: 23374005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.